Directors’ Dealings
Directors Receive Shares in Lieu of Fees

London and New York, 18 October 2010 - Amphion Innovations plc (the “Company”)(LSE: AMP), the developer of medical and technology businesses, today announces that, at a Board meeting held on 13 October 2010, the Company has issued 249,820 ordinary shares, representing 0.19% of the enlarged issued share capital, to certain of its Board members, as their directors’ fees for the second and third quarters to 30 September 2010, priced at 9.10p, being the average of the closing midmarket price for the five days leading up to the market close on 30 September 2010. Following this issue, the directors’ shareholdings in the Company are as follows:

Director Number of New Shares Total Shareholding Percentage of voting rights
R. James Macaleer 149,820 22,740,912 17.12%
Gerard Moufflet 100,000 300,000 0.23%

Director, Anthony Henfrey waived his fees for the second and third quarters 2010.

Admission of the 249,820 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 22 October 2010. Following this allotment the total issued share capital of the Company will increase to 133,498,743 ordinary shares with each share holding one voting right.

For further information please contact:
Amphion Innovations
Charlie Morgan, Director of Communications                      
+1 (212) 210 6224

Charles Stanley Securities, Nominated Advisor
Mark Taylor
+44 020 7149 6000

Cardew Group

Tim Robertson/ Jamie Milton                        
+44 20 7930 0777